The decision could see older adolescents and adults access the treatment for X-linked hypophosphataemia (XLH)
The move secures AZ access to the Japanese drug giant’s experimental antibody drug conjugate
Updated Date: Mon, 20 Jul 2020 00:00:00 EDT
Updated Date: Mon, 20 Jul 2020 00:00:00 EDT
Updated Date: Mon, 20 Jul 2020 00:00:00 EDT
Updated Date: Mon, 20 Jul 2020 00:00:00 EDT
Updated Date: Mon, 20 Jul 2020 00:00:00 EDT
Europe’s COVID-19 vaccine negotiations hit snags with 3 drugmakers: Reuters esagonowsky Mon, 07/27/2020 – 14:58
Pfizer could earn $15B-plus in COVID-19 vaccine sales: analyst esagonowsky Mon, 07/27/2020 – 11:43
